As already mentioned, the core components of Hippo signalling are essentially unaffected by genetic aberrations[3], suggesting that reactivation of the Hippo pathway in cancer cells might restore the proper inhibition of YAP/TAZ by Hippo signalling. Here, YAP1 is linked to cancer.